Article Details

Research Analysts Offer Predictions for Lumos Pharma, Inc.'s Q1 2022 Earnings (NASDAQ:LUMO)

Retrieved on: 2021-03-11 13:52:08

Tags for this article:

Click the tags to see associated articles and topics

Research Analysts Offer Predictions for Lumos Pharma, Inc.'s Q1 2022 Earnings (NASDAQ:LUMO). View article details on hiswai:

Excerpt

Renaissance Technologies LLC now owns 308,812 shares of the company's stock worth $11,028,000 after purchasing an additional 2,700 shares ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up